MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)

CUSIP: 558868105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
22,766,960
Total 13F shares
23,560,972
Share change
+198,821
Total reported value
$13,715,162,458
Put/Call ratio
84%
Price per share
$582.34
Number of holders
384
Value change
+$154,171,159
Number of buys
207
Number of sells
155

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q4 2025

As of 31 Dec 2025, MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by 384 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,560,972 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, VANGUARD GROUP INC, Avoro Capital Advisors LLC, PAULSON & CO. INC., BlackRock, Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 384 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.